Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Cell-penetrating peptides developed to target STAT3 for antitumor effects

Feb. 17, 2021

TLX-591-CDx for prostate cancer imaging receives first E.U. approval in Czech Republic

Feb. 16, 2021

BeiGene patents MAP4K1 inhibitors

Feb. 16, 2021

Preliminary phase II data for eganelisib plus nivolumab in advanced urothelial carcinoma

Feb. 16, 2021

FDA approves Cosela for myeloprotection in patients with extensive-stage SCLC receiving chemotherapy

Feb. 15, 2021

Reata Pharmaceuticals identifies new nitric oxide production inhibitors

Feb. 15, 2021

Tukysa approved in E.U. for HER2-positive locally advanced or metastatic breast cancer

Feb. 12, 2021

Bristol Myers Squibb synthesizes IRAK-4 inhibitors

Feb. 12, 2021

New cancer anorexia therapeutic target identified

Feb. 12, 2021

Dependencies join mutations in precision medicine search

Feb. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...